Abstract:A key element for successful blood transfusion is compatibility of the patient and donor red blood cell (RBC) antigens. Precise antigen matching reduces the risk for immunization and other adverse transfusion outcomes. RBC antigens are encoded by specific genes, which allows developing computational methods for determining antigens from genomic data. We describe here a classification method for determining RBC antigens from genotyping array data. Random forest models for 39 RBC antigens in 14 blood group systems and for human platelet antigen (HPA)-1 were trained and tested using genotype and RBC antigen and HPA-1 typing data available for 1,192 blood donors in the Finnish Blood Service Biobank. The algorithm and models were further evaluated using a validation cohort of 111,667 Danish blood donors. In the Finnish test data set, the median (interquartile range [IQR]) balanced accuracy for 39 models was 99.9 (98.9–100)%. We were able to replicate 34 out of 39 Finnish models in the Danish cohort and the median (IQR) balanced accuracy for classifications was 97.1 (90.1–99.4)%. When applying models trained with the Danish cohort, the median (IQR) balanced accuracy for the 40 Danish models in the Danish test data set was 99.3 (95.1–99.8)%. The RBC antigen and HPA-1 prediction models demonstrated high overall accuracies suitable for probabilistic determination of blood groups and HPA-1 at biobank-scale. Furthermore, population-specific training cohort increased the accuracies of the models. This stand-alone and freely available method is applicable for research and screening for antigen-negative blood donors. Blood transfusion is one of the most common clinical procedures in the hospitals and the key element for safe transfusion is compatibility between the recipient and donor red blood cell antigens. Precise antigen matching reduces the risk for sensitization and other adverse transfusion outcomes. Here we describe a stand-alone and freely available random forest classification method and models for determining red blood cell and human platelet antigens from array technology-based genotyping data. We investigate the performance of models trained with Finnish blood donor biobank data and further validate the method with a large Danish cohort. The results demonstrate high overall accuracy, and the method is suitable for biobank-scale research and screening of antigen-negative donors. The implementation is possible in the local computing environment without sensitive data uploads and requires only a moderate level of bioinformatic skills.

Genetic blood typing by high throughput sequencing

High-sensitivity HLA typing by Saturated Tiling Capture Sequencing (STC-Seq)

Calling for diversity: improving transfusion safety through high-throughput blood group microarray genotyping

Fully genotyping and screening of clinically important blood‐group antigens by MALDI TOF mass spectrometry

When and why is red blood cell genotyping applicable in transfusion medicine: a systematic review of the literature

Automated blood typing of patients

Next Generation Sequencing of Red Blood Cell Antigens in Transfusion Medicine: Systematic Review and Meta-Analysis

Simultaneous high throughput genotyping of 36 blood group systems using NGS based on probe capture technology

An Automatic Lab-on-Disc System for Blood Typing

Forward and reverse typing discrepancy and crossmatch incompatibility of ABO blood groups: cause analysis and treatment

Molecular genotyping versus serological diagnosis for RH blood group typing in sickle cell patients

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Clinical application of ABO blood typing

Comparison of sequence-specific oligonucleotide probe vs next generation sequencing for HLA-A, B, C, DRB1, DRB3/B4/B5, DQA1, DQB1, DPA1, and DPB1 typing: Toward single-pass high-resolution HLA typing in support of solid organ and hematopoietic cell transplant programs

Advancements in HLA Typing Techniques and Their Impact on Transplantation Medicine

Recent Advances of Human Leukocyte Antigen (HLA) Typing Technology Based on High-Throughput Sequencing

A machine-learning method for biobank-scale genetic prediction of blood group antigens

A study of cases with ABO typing discrepancy and the strategy of blood transfusion

The Application of Automatic Blood Transfusion Typing System

Blood Group Typing: From Classical Strategies to the Application of Synthetic Antibodies Generated by Molecular Imprinting

Detecting serologically difficult ABO blood groups using single-molecule real-time sequencing technology